Frost & Sullivan has released a white paper titled, “How Leading Global Pharma Embraces AI to Automate Regulatory and Medical ...

Compensation for clinical trial participants is a sensitive subject. However, it should not be taboo, because there is a major need for reform. Recognition of this need has led to sustained attention ...

Nearly 1 in 30 clinical trials were interrupted by funding cuts to the National Institutes of Health, affecting more than 74,000 patients and research into cancer, infectious disease and more, ...

Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...